After 4 weeks, increase the dose to the maintenance dose of 2.4mg
The most ignored risk of GLP-1 medications is Sarcopenia (muscle loss)
Tirzepatide May Be Considered When A physician determines that dual-receptor therapy may be appropriate based on weight, metabolic risk, prior treatment response, side-effect tolerance, and treatment goals
OFA Files Another Lawsuit Against the FDA, This Time Over Semaglutide Dave Knapp Feb 24, 2025 2 min read Its official: reports submitted to onthepen.com and confirmed by Reuters show that the OFA is once again taking aim at the FDA in federal court, this time over semaglutide
Slowing stomach emptying to increase fullness and reduce appetite
Mounjaro (tirzepatide) also should not be used if you have ever had pancreatitis, medullary thyroid carcinoma (thyroid C cell tumors), or if there is a personal or family history of medullary thyroid cancer or something called the MEN2 (multiple endocrine neoplasias) syndrome